NFKB1 and Cachexia: Moreover, the use of the NF-κB inhibitor PDTC effectively suppressed the upregulation of MuRF1 mediated by TNF-α intervention.412 IL-1, a proinflammatory cytokine with effects similar to those of TNF-α, is also significantly elevated in cachexia patients.